Home › Funds › Renaissance Technologies › NRIX
Renaissance Technologies position in NRIX
NURIX THERAPEUTICS INC · Health Care
Latest position (Q1 2026)118.00K sh
Reported value held$1.83M
Portfolio Weight0.00%
First reportedQ1 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 76.20K | $1.07M | New |
| Q2 2022 | 118.40K | $1.50M | Add |
| Q3 2022 | 73.30K | $955.00K | Reduce |
| Q4 2022 | 118.70K | $1.30K | Add |
| Q1 2023 | 28.90K | $257 | Reduce |
| Q3 2023 | 26.80K | $211 | New |
| Q4 2023 | 115.20K | $1.19K | Add |
| Q1 2024 | 179.30K | $2.64K | Add |
| Q2 2024 | 324.00K | $6.76M | Add |
| Q3 2024 | 246.40K | $5.54M | Reduce |
| Q1 2025 | 59.50K | $706.86K | New |
| Q1 2025 | 59.50K | $706.86K | New |
| Q2 2025 | 21.90K | $249.44K | Reduce |
| Q2 2025 | 21.90K | $249.44K | Reduce |
| Q3 2025 | 184.80K | $1.71M | Add |
| Q1 2026 | 118.00K | $1.83M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- Geode Capital Management 2.54M sh · $61.57M · Q2 2026
- ARK Invest 1.79M sh · $43.50M · Q2 2026
- Capital World Investors 1.79M sh · $43.37M · Q2 2026
- UBS Group AG 917.12K sh · $22.25M · Q2 2026
- Northern Trust Corp 876.07K sh · $21.25M · Q2 2026
- Bank of America Corp 842.09K sh · $20.43M · Q2 2026
- Charles Schwab Investment Management 833.30K sh · $20.22M · Q2 2026
- Goldman Sachs Group 813.59K sh · $19.74M · Q2 2026